Skip to main content

Advertisement

SpringerLink
Log in

An overview on interleukin-1 as a therapeutic agent

  • Published:
Biotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shilo M. Non-specific resistance to infection. Ann Rev Microbil 1959; 13: 255–79.

    Google Scholar 

  2. Cluff LE. Effects of lipopolysaccharides (endotoxins) on susceptibility to infection. J Infect Dis 1970; 122: 205–18.

    PubMed  Google Scholar 

  3. Kimball HR, Williams TW, Wolff SM. Effect of bacterial endotoxin on experimental fungal infections. J Immunol 1968; 100: 24–30.

    PubMed  Google Scholar 

  4. Chedid L, Parant M, Parant F, Lefrancier P, Choay J Lederer E. Enhancement of non-specific resistance to infection by a synthetic immuno-adjuvant (N-acetyl muramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci (USA) 1977; 74: 2089–291.

    Google Scholar 

  5. Ainsworth EJ, Chase HB. Effect of microbial antigens on irradiation mortality in mice. Proc Soc Exp Biol Med 1959; 102: 483–5.

    PubMed  Google Scholar 

  6. Smith WW, Alderman IM, Gillespie RI. Increased survival in irradiated animals treated with bacterial endotoxins. Am J Physiol 1957; 191: 124–30.

    PubMed  Google Scholar 

  7. Parant M, Riveau G, Parant F, Dinarello CA, Wolff SM, Chedid L. Effect of indomethacin on increased bacterial resistance to infection and on febrile responses induced by muramyl dipeptide. J Infect Dis 1980; 142: 708–15.

    PubMed  Google Scholar 

  8. Murphy, PA, Chesney J, Wood WB Jr. Further purification of rabbit leukocytic pyrogen. J Lab Clin Med 1974; 83: 310–9.

    PubMed  Google Scholar 

  9. Dinarello, CA, Renfer L, Wolff SM. Human leukocytic pyrogen: purification and development of radioimmunoassay. Proc Natl Acad Sci (USA) 1977; 74: 4624–7.

    Google Scholar 

  10. Merriman CR, Pulliam LA, Kampschmidt RF. Comparison of leukocytic pyrogen and leukocytic endogenous mediator. Proc Soc Exp Biol Med 1977; 154: 224–7.

    PubMed  Google Scholar 

  11. Gery I, Waksman BH. Potentiation of the T-lymphocyte response to mitogens. II The cellular source of potentiating mediator(s). J Exp Med 1972; 136: 143–55.

    PubMed  Google Scholar 

  12. Kampschmidt RF. Infection, inflammation and interleukin-I. Lymphokine Res 1984; 2: 97–110.

    Google Scholar 

  13. Dinarello CA, Goldin NP, Wolff SM. Demonstration and characterization of two distinct human leukocytic pyrogens. J Exp Med 1974; 139: 1369–81.

    PubMed  Google Scholar 

  14. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc Natl Acad Sci (USA) 1984; 81: 7907–11.

    Google Scholar 

  15. Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan YCE, Collier K, Semionow R, Chua AO, Mizel SB. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 1984; 312: 458–62.

    PubMed  Google Scholar 

  16. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 1985; 135: 3962–8.

    PubMed  Google Scholar 

  17. Nakamura S, Nakata K, Kashimoti S, Yoshida H, Yamada M. Anti-tumor effect of recombinant human interleukin-I alpha against murine syngeneic tumors. Jpn J Cancer Res 1986; 77: 767–73.

    PubMed  Google Scholar 

  18. Neta R, Douches SD, Oppenheim JJ. Interleukin-1 is a radioprotector. J Immunol 1986; 136: 2483–5.

    PubMed  Google Scholar 

  19. Brown KM, Muchmore AV, Rosenstreich DL. Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 9119–23.

    PubMed  Google Scholar 

  20. Rosenstreich DL, Yost SL, Brown KM. Human urine-derived inhibitors of interleukin 1. Rev Infect Dis 1987; 9: 5594–8.

    Google Scholar 

  21. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR. A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 1987; 139: 1546–9.

    PubMed  Google Scholar 

  22. van der Meer JWM, Rubin RH, Pasternack M, Meadearis DN, Lynch P, Dinarello CA. The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection. Biotherapy 1989.

  23. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor levels are regulated independently in septic shock and experimental endotoxin fever. 1989; J Infect Dis, in press

  24. Bagby CG Jr, Dinarello CA, Neerhout RC, Ridgeway D, MacCall E. Interleukin-l-dependent paracrine granulocytopoiesis in chronic granulocytic leukemia of the juvenile type. J Clin Invest 1988; 82: 1430–36.

    PubMed  Google Scholar 

  25. Rosoff PM, Savage N, Dinarello CA. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988; 54: 73–81.

    PubMed  Google Scholar 

  26. Neta R, Douches SD, Oppenheim JJ. Radioprotection by interleukin-1. In: Golstein G, Bach JF, Wigzal H, eds. Immunoregulation by characterized polypeptides. UCLA Symposia on Molecular Biology.

  27. Vogel SN, Douches SD, Kaufman EN, Neta R. Induction of colony stimulating factor in vivo by recombinant interleukin-lα and recombinant tumor necrosis factor α. J Immunol 1987; 138: 2143–8.

    PubMed  Google Scholar 

  28. Ozaki Y, Ohashi T, Minami A, Nakamura SI. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1alpha. Infec Immun 1987; 55: 1436–42.

    Google Scholar 

  29. Czuprynski CJ, Brown JF, Young KM, Cooley AJ, Kurz RS. Effects of murine recombinant interleukin-1alpha on the host response to bacterial infection. J Immunol 1988; 140: 962–8.

    PubMed  Google Scholar 

  30. van der Meer JWM, Barza M, Wolff SM, Dinarello CA. A low dose of interleukin-1 protects granulocytopenic mice from lethal Gram-negative infection. Proc Natl Acad Sci (USA) 1988; 85: 1620–3.

    Google Scholar 

  31. Holtmann H, Wallach D. Downregulation of the receptors for tumor necrosis factor by interleukin-1 and phorbol myristate acetate. J Immunol 1987; 139: 1511–5.

    Google Scholar 

  32. North RJ, Neubauer RH, Huang JJH, Newton RC, Loveless SE. Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. J Exp Med 1988; 168: 2031–43.

    PubMed  Google Scholar 

  33. Vaishnav TN, Kumar KS, Weiss JF, Neta R. Induction of superoxide dismutase: a mechanism for radioprotection by interleukin-1 (IL-1). 37th Annual Meeting of the Radiation Research Society, Seattle, Washington, 1989.

  34. Staruch MJ, Wood DD. The adjuvanticity of interleukin 1 in vivo. J Immunol 1983; 130: 2191–4.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Tufts University School of Medicine, New England Medical Center, 02111, Boston, MA, USA

    Charles A. Dinarello

  2. Division of Experimental Hematology, Armed Forces Radiobiology Research Institute, 20814, Bethesda, MD, USA

    Ruth Neta

Authors
  1. Charles A. Dinarello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruth Neta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinarello, C.A., Neta, R. An overview on interleukin-1 as a therapeutic agent. Biotherapy 1, 245–254 (1989). https://doi.org/10.1007/BF02171000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02171000

Keywords

Search

Navigation